DS3790
/ Daiichi Sankyo
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 19, 2025
A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies
(clinicaltrials.gov)
- P1/2 | N=420 | Recruiting | Sponsor: Daiichi Sankyo | Not yet recruiting ➔ Recruiting
Enrollment open • First-in-human • Hematological Malignancies • Oncology
1 to 1
Of
1
Go to page
1